Literature DB >> 1686949

[Drug treatment of anxiety disorders].

H Scholz1, R Lhotka.   

Abstract

Current customary medication with anxiolytic potential has different main-points of impact and individual potentials of risk, which influence strategies of therapy in a limiting way. Benzodiazepines--which are very effective in various anxiety-disorders--can therefore only be applied under well controllable conditions within a limited period of time, in order to reduce the risks of dependency. Also administration of low-doses neuroleptica--which within these doses also show a high potential of anxiety-impact beside a high tolerance--must be limited to a period of two or three months to prevent late development of dyskinesias. Main indications for the application of antidepressive drugs are panic-conditions, cases of phobia and depressive anxiety. In the following a therapy-pattern for management of panic-conditions with Clomipramin will be gone into more detailed. Complementary anxiolytic characteristics of Buspiron and beta-blockers with their specific indication-fields will be brought up.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686949

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  1 in total

1.  Decreased anxiety in mice lacking the organic cation transporter 3.

Authors:  Thomas Wultsch; Gundula Grimberg; Angelika Schmitt; Evelin Painsipp; Heike Wetzstein; Alexandra Frauke Stephanie Breitenkamp; Dirk Gründemann; Edgar Schömig; Klaus-Peter Lesch; Manfred Gerlach; Andreas Reif
Journal:  J Neural Transm (Vienna)       Date:  2009-03-11       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.